SCHEMBL12317224

SCHEMBL12317224

CC(C)=Cc1cccc2nc(NC(=O)c3cccnc3)nn12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K5 Q99683 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ JAK2 O60674 2/20 0.46
▸ TDP2 O95551 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ TYK2 P29597 1/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ ROCK2 O75116 1/20 0.42
▸ ROCK1 Q13464 1/20 0.42
▸ HTT P42858 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ KCNK3 O14649 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2772969 0.99 MAP3K5 (0.46) MAP3K5HSD17B10HPGDALOX15JAK2
SCHEMBL2774570 0.81 MAP3K5 (0.51) MAP3K5HSD17B10HPGDALOX15JAK2
SCHEMBL2773629 0.81 TDP2 (0.52) MAP3K5HSD17B10HPGDALOX15JAK2
SCHEMBL2789227 0.76 SMN1; SMN2 (0.53) MAP3K5HSD17B10HPGDALOX15JAK2
SCHEMBL2789556 0.76 HSD17B10 (0.56) MAP3K5HSD17B10HPGDALOX15JAK2
SCHEMBL2787509 0.75 MAP3K5 (0.74) MAP3K5HSD17B10HPGDALOX15JAK2
SCHEMBL2788953 0.75 JAK2 (0.49) MAP3K5HSD17B10HPGDALOX15JAK2
SCHEMBL2771164 0.75 NPC1 (0.52) MAP3K5HSD17B10HPGDALOX15JAK2
SCHEMBL2789560 0.75 TDP1 (0.54) MAP3K5HSD17B10HPGDALOX15TDP2
SCHEMBL2790092 0.74 JAK2 (0.53) MAP3K5HSD17B10HPGDALOX15JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120238565-A1 TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE AS ASK INHIBITORS MERCK SERONO SA (CH) 2012-09-20 — — US disclosed
US-8263595-B2 Triazolopyridine compounds and their use as ask inhibitors MERCK SERONO SA (CH) 2012-09-11 — — US disclosed
US-20100197681-A1 Triazolopyridine Compounds and Their Use as Ask Inhibitors MERCK SERONO SA (CH) 2010-08-05 — — US disclosed
WO-2009027283-A1 TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE AS ASK INHIBITORS MERCK SERONO S.A. (CH) 2009-03-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197681-A1 Triazolopyridine Compounds and Their Use as Ask Inhibitors MAP3K5, MAPKAPK5, MAP3K9 MAP3K5 1/4885HSD17B10 4398/4885HPGD 2443/4885
US-20120238565-A1 TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE AS ASK INHIBITORS MAP3K5, MAPKAPK5, MAP3K9 MAP3K5 1/4885HSD17B10 4398/4885HPGD 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback